Your browser doesn't support javascript.
loading
Inhibiting with-no-lysine kinases enhances K+/Cl- cotransporter 2 activity and limits status epilepticus.
Lee, Kathryn L; Abiraman, Krithika; Lucaj, Christopher; Ollerhead, Thomas A; Brandon, Nicholas J; Deeb, Tarek Z; Maguire, Jamie; Moss, Stephen J.
Afiliação
  • Lee KL; Department of Neuroscience, Tufts University School of Medicine, Boston, MA 02111, USA.
  • Abiraman K; Department of Neuroscience, Tufts University School of Medicine, Boston, MA 02111, USA.
  • Lucaj C; Department of Neuroscience, Tufts University School of Medicine, Boston, MA 02111, USA.
  • Ollerhead TA; AstraZeneca-Tufts Laboratory of Basic and Translational Neuroscience, Tufts University School of Medicine, Boston, MA 02111, USA.
  • Brandon NJ; Department of Neuroscience, Tufts University School of Medicine, Boston, MA 02111, USA.
  • Deeb TZ; Neuroscience, BioPharmaceuticals R&D, AstraZeneca, Boston, MA 02451, USA.
  • Maguire J; Department of Neuroscience, Tufts University School of Medicine, Boston, MA 02111, USA.
  • Moss SJ; AstraZeneca-Tufts Laboratory of Basic and Translational Neuroscience, Tufts University School of Medicine, Boston, MA 02111, USA.
Brain ; 145(3): 950-963, 2022 04 29.
Article em En | MEDLINE | ID: mdl-34528073

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Estado Epiléptico / Simportadores / Epilepsia Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Estado Epiléptico / Simportadores / Epilepsia Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article